Skip to main content
Premium Trial:

Request an Annual Quote

Analytik Jena's FY 2012 Revenues Climb 9 Percent

NEW YORK (GenomeWeb News) – German analytic instrument firm Analytik Jena today said that revenues for its Fiscal Year 2012 increased 9 percent year over year.

For the fiscal year ended Sept. 30, Analytik Jena posted €94.0 million ($124.4 million) in revenues, up from €86.3 million a year ago.

Analytical Instrumentation, the company's largest segment, recorded €60.0 million in revenues, up from €53.2 million a year ago, it said in a statement, while Life Science was virtually flat at €28.2 million, compared to €28.3 million a year ago.

The firm's Optics business had sales of €5.8 million, up from €4.8 million in FY 2011.

"We are working intensively on the international positioning of the comparatively young Life Science segment, and have made progress in some important areas," Analytik Jena CEO Klaus Berka said in the company's statement. "For example, double-digit growth in revenue from PCR products and reagents meant that we were able to compensate for the lower revenue from two subsidiaries."

The firm's R&D costs were reduced 8 percent to €7.3million from €7.9 million a year ago, while SG&A spending rose 9 percent to €33.6 million from €30.9 million.

Analytik Jena's profits attributable to shareholders of the parent firm for FY 2012 increased to €3.2 million, or €.59 per share, compared to a loss of €23,000, or €.03 per share, a year ago.

The firm had €21.5 million in cash and cash equivalents as of the Sept. 30.

"The aim of the Analytik Jena Group for the coming year is to further reinforce and expand our position on the global markets," Berka said. "Our objectives are to generate further revenue growth, exceed the highs recorded in 2011/2012, and ensure qualitative earnings growth."

Revenue growth and profits will be driven by the company's Asian business, which in FY 2012 grew 31 percent year over year, as well as new product launches, it said.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.